Merck & Co (NY:MRK)

144.30 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

99 100 Next >

2 Strong Healthcare Stock Picks for Value Investors ↗

November 12, 2025

Value-driven plays abound in the top healthcare stocks.

Via The Motley Fool

Topics Intellectual Property

2 Stocks Down 13% and 34% to Buy Right Now ↗

November 12, 2025

It's been a year to forget for these two companies, but brighter days are ahead.

Via The Motley Fool

Topics Intellectual Property World Trade

Google To Run Ohio Data Centers On Solar Power From TotalEnergies ↗

November 12, 2025

TotalEnergies and Google have signed a 15-year PPA for renewable electricity. The deal aligns with both companies' goals.

Via Benzinga

Dow Jones Industrial Average Soars to Record High: A Nuanced Signal for the Economy

November 11, 2025

NEW YORK, NY – November 11, 2025 – The Dow Jones Industrial Average (DJIA) has reached an unprecedented milestone today, soaring to a new all-time high of 47,927.96, a robust gain of 559.33 points...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Merck Stock Rises Upon Receipt Of $700M In Funding For Experimental Cancer Drug ↗

November 04, 2025

Via Stocktwits

Dow Jones Industrial Average Soars to New All-Time High Amidst Shifting Market Dynamics

November 11, 2025

New York, NY – November 11, 2025 – The Dow Jones Industrial Average (DJIA) has today surged to an unprecedented all-time high, pushing past significant milestones and reinforcing a complex, yet largely...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know

November 11, 2025

A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...

Via StockStory

Topics Artificial Intelligence Stocks

Exploring the top movers within the S&P500 index during today's session. ↗

November 11, 2025

Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.

Via Chartmill

What's going on in today's session: S&P500 movers ↗

November 11, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Who's Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market? ↗

November 11, 2025

Three large pharmaceutical makers are jockeying for position in the rapidly expanding market for GLP-1 drugs.

Via The Motley Fool

Healthcare Sector Navigates Turbulent Waters: Innovation Surges Amidst Political Headwinds

November 10, 2025

New York, NY – November 10, 2025 – The S&P 500 Healthcare sector presented a mixed picture today, with the broader index showing a modest uptick while significant segments, particularly health insurers...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Cliff Asness: The Stock Market is Expensive, Not a Bubble – A Call for Rationality in a Less Efficient Market

November 10, 2025

New York, NY – November 10, 2025 – In a financial landscape often characterized by extremes, Cliff Asness, the influential co-founder of AQR Capital Management, offers a nuanced yet stark assessment of...

Via MarketMinute

Topics Economy

Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Adults with Heterozygous Familial Hypercholesterolemia (HeFH) in Phase 3 CORALreef HeFH Trial

November 09, 2025

From Merck & Co., Inc.

Via Business Wire

Merck Takes On Amgen, Regeneron, Lowering Stubbornly High Cholesterol By 60% ↗

November 08, 2025

Merck said Saturday its new pill — a possible rival to Regeneron and Amgen — lowered high cholesterol by almost 60%.

Via Investor's Business Daily

Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Phase 3 CORALreef Lipids Trial

November 08, 2025

From Merck & Co., Inc.

Via Business Wire

Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally

November 07, 2025

The biotech sector is currently experiencing a robust rally, a significant turnaround from a period of subdued performance. This resurgence is primarily fueled by a wave of promising drug trial results...

Via MarketMinute

Topics Artificial Intelligence Intellectual Property

Herkimer College Pioneers New AI-Business Degree to Forge Future-Ready Workforce

November 07, 2025

Herkimer, NY – November 7, 2025 – In a significant move signaling a proactive response to the escalating demand for artificial intelligence (AI) expertise in the business world, Herkimer County...

Via TokenRing AI

Topics Artificial Intelligence Economy Fraud

3 Dirt Cheap Stocks to Buy With $1,000 Right Now ↗

November 07, 2025

The overall market may be priced very richly here, but a handful of names haven't been swept up in artificial intelligence (AI)-driven mania.

Via The Motley Fool

Topics Artificial Intelligence Intellectual Property

2 Safe-and-Steady Stocks Worth Your Attention and 1 We Turn Down

November 06, 2025

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Via StockStory

ESG Investing's Future: Navigating Regulatory Currents and Sustainable Fund Performance

November 06, 2025

November 6, 2025 – Environmental, Social, and Governance (ESG) investing finds itself at a pivotal juncture, grappling with a complex web of evolving global regulations and shifting political...

Via MarketMinute

Topics Artificial Intelligence Bonds Climate Change

Navigating the Volatility: Q3 2025 Earnings Season Delivers Both Cheers and Concerns

November 06, 2025

The third-quarter 2025 earnings season, largely drawing to a close in early November, has proven to be a dynamic and often surprising period for investors. While a significant majority of S&P 500...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Ligand Pharmaceuticals Soars to New Heights: A Deep Dive into its 52-Week High

November 06, 2025

San Diego, CA – November 6, 2025 – Ligand Pharmaceuticals (NASDAQ: LGND) has recently captured the financial spotlight, with its stock hitting a remarkable 52-week high of $197.78 on November 6, 2025....

Via MarketMinute

Topics Intellectual Property

Merck & Co. Inc. (NYSE:MRK) Presents a Compelling Case for Dividend Investors ↗

November 06, 2025

Build a resilient dividend portfolio with Merck (MRK). It offers a strong 3.86% yield, consistent growth, and is backed by top-tier profitability and financial health.

Via Chartmill

3 Reasons Investors Love Merck (MRK)

November 05, 2025

Although Merck (currently trading at $84.57 per share) has gained 7% over the last six months, it has trailed the S&P 500’s 21.3% return during that period. This may have investors wondering how to...

Via StockStory

Topics Stocks Supply Chain

MarketMinute: The Rise of Precision Swine Farming – A New Frontier in Agri-Tech Investment

November 05, 2025

The global agricultural landscape is undergoing a profound transformation, with specialized niche markets emerging as significant drivers of innovation and investment. Among these, the precision swine...

Via MarketMinute

Topics Artificial Intelligence Supply Chain

Obesity Drugmakers Face Shifting Tides: Novo Nordisk Plunges While Eli Lilly Soars

November 05, 2025

The burgeoning market for obesity and diabetes treatments, particularly GLP-1 receptor agonists, is witnessing a dramatic divergence in fortunes among its leading players. As of November 5, 2025, Novo...

Via MarketMinute

Topics Economy

AI Achieves Atomic Precision in Antibody Design: A New Era for Drug Discovery Dawns

November 05, 2025

Seattle, WA – November 5, 2025 – In a monumental leap for biotechnology and artificial intelligence, Nobel Laureate David Baker’s lab at the University of Washington’s Institute for Protein Design...

Via TokenRing AI

Topics Artificial Intelligence Intellectual Property

AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential

November 04, 2025

The burgeoning fields of cell and gene therapy (CGT) are on the cusp of a profound revolution, driven by the relentless advancements in artificial intelligence. This transformative impact was a central...

Via TokenRing AI

Topics Artificial Intelligence

Why Merck Is Sinking This Week ↗

November 04, 2025

Investors were unimpressed with Merck's Q3 financial results.

Via The Motley Fool

Topics Intellectual Property

Merck Enters into Research and Development Funding Agreement with Blackstone Life Sciences for Sacituzumab Tirumotecan (sac-TMT)

November 04, 2025

From Merck & Co., Inc.

Via Business Wire

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.